ACHV

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company based in Vancouver, Canada, focused on transforming the treatment of smoking and nicotine addiction. The company is advancing its lead product, cytisinicline, a novel therapeutic agent demonstrated to facilitate smoking cessation, through rigorous clinical trials. With a commitment to addressing one of the most significant public health challenges globally, Achieve Life Sciences aims to improve patient outcomes and contribute to reduced tobacco-related harm both in the U.S. and internationally.